{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:28:47Z","timestamp":1791876527656,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["RG-1440-136"],"award-info":[{"award-number":["RG-1440-136"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jneuroim.2020.577430","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T10:40:18Z","timestamp":1603536018000},"page":"577430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Upregulation of interleukin (IL)-31, a cytokine producing CXCR1 peripheral immune cells, contributes to the immune abnormalities of autism spectrum disorder"],"prefix":"10.1016","volume":"349","author":[{"given":"Sheikh F.","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushtaq A.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A.","family":"Bakheet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila Y.","family":"AL-Ayadhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz M.S.","family":"Alsaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Assiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneen A.","family":"Al-Mazroua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabry M.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2020.577430_bb0005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cyto.2012.11.015","article-title":"Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study","volume":"6","author":"Abdallah","year":"2013","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.jneuroim.2020.577430_bb0010","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1007\/s12035-016-9977-0","article-title":"Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism","volume":"54","author":"Ahmad","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molimm.2016.12.019","article-title":"Imbalance between the anti- and pro-inflammatory milieu in blood leukocytes of autistic children","volume":"82","author":"Ahmad","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0020","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.intimp.2018.10.027","article-title":"Dysregulation of the expression of HLA-DR, costimulatory molecule, and chemokine receptors on immune cells in children with autism","volume":"65","author":"Ahmad","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0025","series-title":"Diagnostic and Statistical Manual of Mental Disorders, 5th ed (DSM-5) Arlington, VA","author":"American Psychiatric Association","year":"2015"},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577430_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.1205707","article-title":"The immune response in autism: a new frontier for autism research","volume":"80","author":"Ashwood","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2010.08.003","article-title":"Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome","volume":"25","author":"Ashwood","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0040","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbi.2010.09.002","article-title":"Altered T cell responses in autism","volume":"25","author":"Ashwood","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0045","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jneuroim.2010.10.025","article-title":"Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders","volume":"232","author":"Ashwood","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577430_bb0050","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1542\/peds.2008-2445","article-title":"Association of family history of autoimmune diseases and autism spectrum disorders","volume":"124","author":"Atlad\u00f3ttir","year":"2009","journal-title":"Pediatrics."},{"issue":"7090","key":"10.1016\/j.jneuroim.2020.577430_bb0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2008.04.012","article-title":"Neuron-microglia signaling: chemokines as versatile messengers","volume":"198","author":"Biber","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577430_bb0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.bjp.0706987","article-title":"Suberosin inhibits proliferation of human peripheral blood mononuclear cells through the modulation of the transcription factors NF-AT and NF-kappaB","volume":"150","author":"Chen","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"6276","key":"10.1016\/j.jneuroim.2020.577430_bb0070","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.aad0314","article-title":"The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring","volume":"351","author":"Choi","year":"2016","journal-title":"Science."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ddmec.2007.09.001","article-title":"Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder","volume":"4","author":"Clunes","year":"2007","journal-title":"Drug Discov. Today Dis. Mech."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0080","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ni.2027","article-title":"ROR\u03b3t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation","volume":"12","author":"Codarri","year":"2011","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577430_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10803-004-1038-2","article-title":"Specific genetic disorders and autism: clinical contribution towards their identification","volume":"35","author":"Cohen","year":"2005","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0090","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577430_bb0095","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.yexmp.2015.07.010","article-title":"IL-9 signaling affects central nervous system resident cells during inflammatory stimuli","volume":"99","author":"Ding","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-5728(00)00371-4","article-title":"Astrocytes express functional chemokine receptors","volume":"111","author":"Dorf","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577430_bb0105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.biopsych.2016.08.031","article-title":"Autoimmunity, autoantibodies, and autism spectrum disorder","volume":"81","author":"Edmiston","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2020.577430_bb0110","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion-from mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00281-016-0604-y","article-title":"Th9 cells in the pathogenesis of EAE and multiple sclerosis","volume":"39","author":"Elyaman","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0120","first-page":"463","article-title":"Autoimmunity in autism","volume":"10","author":"Enstrom","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.jneuroim.2020.577430_bb0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jocn.2018.11.024","article-title":"Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders","volume":"61","author":"Gao","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2040-2392-2-13","article-title":"Increased midgestational IFN-\u03b3, IL-4 and IL-5 in women bearing a child with autism: a case-control study","volume":"2","author":"Goines","year":"2011","journal-title":"Mol. Autism."},{"issue":"6","key":"10.1016\/j.jneuroim.2020.577430_bb0135","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.4049\/jimmunol.1003049","article-title":"A brief history of IL-9","volume":"186","author":"Goswami","year":"2011","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.jneuroim.2020.577430_bb0140","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01881-16","article-title":"STAT1 signaling in astrocytes is essential for control of infection in the central nervous system","volume":"7","author":"Hidano","year":"2016","journal-title":"mBio"},{"issue":"31","key":"10.1016\/j.jneuroim.2020.577430_bb0145","doi-asserted-by":"crossref","first-page":"12776","DOI":"10.1073\/pnas.1202556109","article-title":"Modeling an autism risk factor in mice leads to permanent immune dysregulation","volume":"109","author":"Hsiao","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0150","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12974-014-0187-2","article-title":"Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: an inflammatory subtype?","volume":"11","author":"Jyonouchi","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2020.577430_bb0160","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1398-9995.2009.02255.x","article-title":"Interleukin (IL)-31 induces proinflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins","volume":"65","author":"Kasraie","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jneuroim.2020.577430_bb0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1742-2094-8-139","article-title":"Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide","volume":"8","author":"Kovac","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2020.577430_bb0170","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.fct.2013.05.031","article-title":"Suppression of iNOS and COX-2 expression by flavokawain a via blockade of NF-\u03baB and AP-1 activation in RAW 264.7 macrophages","volume":"58","author":"Kwon","year":"2013","journal-title":"Food Chem. Toxicol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2020.577430_bb0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.12.002","article-title":"Elevated immune response in the brain of autistic patients","volume":"207","author":"Li","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577430_bb0180","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12264-017-0103-8","article-title":"The immune system, cytokines, and biomarkers in autism spectrum disorder","volume":"33","author":"Masi","year":"2017","journal-title":"Neurosci. Bull."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2020.577430_bb0185","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jneuroim.2005.11.007","article-title":"Elevated cytokine levels in children with autism spectrum disorder","volume":"172","author":"Molloy","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577430_bb0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cytogfr.2009.02.002","article-title":"Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease","volume":"20","author":"Monteleone","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbi.2016.12.024","article-title":"Toll-like receptor 4 signaling is associated with upregulated NADPH oxidase expression in peripheral T cells of children with autism","volume":"61","author":"Nadeem","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0200","doi-asserted-by":"crossref","first-page":"104554","DOI":"10.1016\/j.psyneuen.2019.104554","article-title":"Differential regulation of Nrf2 is linked to elevated inflammation and nitrative stress in monocytes of children with autism","volume":"113","author":"Nadeem","year":"2019","journal-title":"Psychoneuroendocrinology."},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577430_bb0205","doi-asserted-by":"crossref","first-page":"e19488","DOI":"10.1371\/journal.pone.0019488","article-title":"A study of nuclear transcription factor-kappa B in childhood autism","volume":"6","author":"Naik","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2020.577430_bb0210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cytogfr.2016.02.002","article-title":"IL-9 signaling as key driver of chronic inflammation in mucosal immunity","volume":"29","author":"Neurath","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0215","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbi.2011.08.007","article-title":"The role of immune dysfunction in the pathophysiology of autism","volume":"26","author":"Onore","year":"2012","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.jneuroim.2020.577430_bb0220","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1007\/s11064-011-0547-6","article-title":"Activation of STAT1 in neurons following spinal cord injury in mice","volume":"36","author":"Osuka","year":"2011","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577430_bb0225","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1046\/j.1471-4159.2001.00469.x","article-title":"The chemokine interleukin-8 acutely reduces ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs","volume":"78","author":"Puma","year":"2001","journal-title":"J. Neurochem."},{"issue":"18","key":"10.1016\/j.jneuroim.2020.577430_bb0230","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1523\/JNEUROSCI.4658-15.2016","article-title":"Inhibition of the JAK\/STAT pathway protects against \u03b1-synuclein-induced neuroinflammation and dopaminergic neurodegeneration","volume":"36","author":"Qin","year":"2016","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577430_bb0235","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11882-014-0423-y","article-title":"Interleukin-31: a novel diagnostic marker of allergic diseases","volume":"14","author":"Rabenhorst","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jneuroim.2020.577430_bb0240","doi-asserted-by":"crossref","first-page":"e56595","DOI":"10.1371\/journal.pone.0056595","article-title":"Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signalling","volume":"8","author":"Raveney","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577430_bb0245","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbi.2010.12.004","article-title":"Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer\u2019s disease","volume":"25","author":"Saresella","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0250","series-title":"The Childhood Autism Rating Scale (CARS): For Diagnostic Screening and Classification of Autism","author":"Schopler","year":"1986"},{"issue":"9","key":"10.1016\/j.jneuroim.2020.577430_bb0255","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.3390\/ijerph10094261","article-title":"Epigenetic findings in autism: new perspectives for therapy","volume":"10","author":"Siniscalco","year":"2013","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577430_bb0260","doi-asserted-by":"crossref","first-page":"e60394","DOI":"10.1371\/journal.pone.0060394","article-title":"The tolerogenic peptide, hCDR1, down-regulates the expression of interferon-\u03b1 in murine and human systemic lupus erythematosus","volume":"8","author":"Sthoeger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2020.577430_bb0265","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4","article-title":"Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation","volume":"44","author":"Tak","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0270","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fnins.2016.00463","article-title":"Common genetic variants found in HLA and KIR immune genes in autism spectrum disorder","volume":"10","author":"Torres","year":"2016","journal-title":"Front. Neurosci."},{"issue":"9","key":"10.1016\/j.jneuroim.2020.577430_bb1010","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1038\/tp.2015.142","article-title":"Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6","volume":"5","author":"Tsilioni","year":"2015","journal-title":"Transl Psychiatry"},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577430_bb0275","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ajpath.2010.10.043","article-title":"IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain","volume":"178","author":"Tzartos","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577430_bb0280","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577430_bb0285","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s11481-015-9598-9","article-title":"Celastrol ameliorates EAE induction by suppressing pathogenic T cell responses in the peripheral and central nervous systems","volume":"10","author":"Wang","year":"2015","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577430_bb0290","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/cei.12441","article-title":"Impact of suppressing retinoic acid-related orphan receptor gamma t (ROR)\u03b3t in ameliorating central nervous system autoimmunity","volume":"179","author":"Yang","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577430_bb0295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fpsyt.2011.00027","article-title":"Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation","volume":"2","author":"Young","year":"2011","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jneuroim.2020.577430_bb0300","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbi.2015.02.001","article-title":"Immune mediated conditions in autism spectrum disorders","volume":"46","author":"Zerbo","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577430_bb0305","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/cns.12774","article-title":"Th2 axis-related cytokines in patients with neuromyelitis optica spectrum disorders","volume":"24","author":"Zhang","year":"2018","journal-title":"CNS Neurosci. Ther."},{"issue":"7","key":"10.1016\/j.jneuroim.2020.577430_bb0310","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.1003307","article-title":"IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes","volume":"186","author":"Zhou","year":"2011","journal-title":"J. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820306913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820306913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:39:07Z","timestamp":1759048747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572820306913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":63,"alternative-id":["S0165572820306913"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577430","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulation of interleukin (IL)-31, a cytokine producing CXCR1 peripheral immune cells, contributes to the immune abnormalities of autism spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577430"}}